Omass Therapeutics Is A Biotechnology Company Based In Oxfordukand Was Established As A Spin Out From Oxford Universityoriginally Founded As Omass Technologies In 2016It Rebranded In 2018 To Concentrateon Developing Its Own Therapeuticsthecompany Is Known For Its Innovativedrug Discovery Approachutilizing Its Proprietary Odyssiona C Technology Platformthis Platform Integrates Advanced Biochemistry Techniques And Next Generation Mass Spectrometry To Exploretarget Molecules And Their Interactions In Their Natural Environments Thecompany Specializes In Discovering Medicines For Validated Target Ecosystemsincluding Membraneproteins And Gpcrsomass Therapeutics Aims To Develop Small Moleculetherapeutics For Rarediseases And Immunological Conditionsit Has Garnered Significant Attention And Investment From Major Pharmaceutical And Biotechnology Firmsreflecting Confidencein Its Technology And Potentialwith Over $160 Million Raised From A Diversegroup Of Investorsomass Therapeutics Has Been Recognized As A Promising Player In Thebiotech Industryincluding Being Named Afierce15Winner By Fiercebiotech In 2024
No conferences found for this company.
| Company Name | Omass Therapeutics Ltd |
| Country |
United Kingdom
|
| Address | The Schrodinger Building Heatley Road The Oxford Science Park Oxford Ox4 4ge |
| Telephone | Login to View |
| Login to View |
